MIRA INFORM REPORT

 

 

Report Date :

31.08.2013

 

IDENTIFICATION DETAILS

 

Name :

LABORATORIOS MAR S.A.

 

 

Registered Office :

Avda. Gaona 3875, Buenos Aires City, (1407)

 

 

Country :

Argentina

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

03.03.1999

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Processing and marketing of medical specialties for human use.

 

 

No. of Employees :

35

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

66,000 USD

Status :

Moderate

Payment Behaviour :

No complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

Argentina

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

argentina ECONOMIC OVERVIEW

 

Argentina benefits from rich natural resources, a highly literate population, an export-oriented agricultural sector, and a diversified industrial base. Although one of the world's wealthiest countries 100 years ago, Argentina suffered during most of the 20th century from recurring economic crises, persistent fiscal and current account deficits, high inflation, mounting external debt, and capital flight. A severe depression, growing public and external indebtedness, and an unprecedented bank run culminated in 2001 in the most serious economic, social, and political crisis in the country's turbulent history. Interim President Adolfo RODRIGUEZ SAA declared a default - at the time the largest ever - on the government's foreign debt in December of that year, and abruptly resigned only a few days after taking office. His successor, Eduardo DUHALDE, announced an end to the peso's decade-long 1-to-1 peg to the US dollar in early 2002. The economy bottomed out that year, with real GDP 18% smaller than in 1998 and almost 60% of Argentines under the poverty line. Real GDP rebounded to grow by an average 8.5% annually over the subsequent six years, taking advantage of previously idled industrial capacity and labor, an audacious debt restructuring and reduced debt burden, excellent international financial conditions, and expansionary monetary and fiscal policies. Inflation also increased, however, during the administration of President Nestor KIRCHNER, which responded with price restraints on businesses, as well as export taxes and restraints, and beginning in 2007, with understating inflation data. Cristina FERNANDEZ DE KIRCHNER succeeded her husband as President in late 2007, and the rapid economic growth of previous years began to slow sharply the following year as government policies held back exports and the world economy fell into recession. The economy in 2010 rebounded strongly from the 2009 recession, but has slowed since late 2011 even as the government continued to rely on expansionary fiscal and monetary policies, which have kept inflation in the double digits. The government expanded state intervention in the economy throughout 2012. In May the Congress approved the nationalization of the oil company YPF from Spain's Repsol. The government expanded formal and informal measures to restrict imports during the year, including a requirement for pre-registration and pre-approval of all imports. In July the government also further tightened currency controls in an effort to bolster foreign reserves and stem capital flight.

 

Source : CIA

 

 


Registered Name

 

LABORATORIOS MAR S.A.

C.U.I.T. 30-70207068-2

 

 

Summary

 

BEGINNER OF ACTIVITIES. INCORPORATED IN 1999. BALANCE SHEET AS OF 31/03/2013: RESULT

POSITIVE OF REASONABLE IMPORTANCE AND ADEQUATE STRUCTURE ECONOMIC/FINANCIAL. FIT FOR OPERATIONS OF MEDIUM IMPORTANCE AND ADDITIONAL GUARANTEES.

 

 

Operations

 

> PROCESSING AND MARKETING OF MEDICAL SPECIALTIES FOR HUMAN USE.

 

 

Legal Structure

 

LEGAL FORM:                          PUBLIC LIMITED COMPANY

CREATED:                                03/03/1999

REGISTERED                           R.P.C.: 1999

DURATION:                               99 YEARS

END OF FISCAL YEAR:             31 MARCH

Credit Limit                            66,000 USD

 

 

Contact

 

Accountant:                               Dario De Valle

Legal and operative address:       Avda. Gaona 3875, Buenos Aires City, (1407) Argentina.

Phone:                                      (54-11) 4582-5090 y 4582.2929

E.Mail:                                      administracion@laboratoriosmar.com.ar

 

 

Partners

 

PRESIDENT:                             DIEGO EMILIANO MARTINEZ

V.PRESIDENT:              RODRIGO OSVALDO MARTINEZ URIA

DIRECTOR:                               SILVINA GABRIELA MARTINEZ URIA

 

Use of signature:                        President and V.President.

 


This Board was appointed Special Meeting of July 29, 2011 Registration 1147 where he also will increase its share capital stated in the corresponding items.

 

It was published in the Official Gazette of Argentina No. 32281 of November 21, 2011.

 

 

Corporate Stock

 

Ordinary shares:

----------------

Subscribed and integrated $ 1.068.666.-

 

 

Personal Information

 

MARTINEZ URIA RODRIGO OSVALDO:

-------------------------------

argentino, married, born 23/1/1975, D.N.I. No. 24.424.476

MARTINEZ URIA SILVINA GABRIELA:

------------------------------

argentina, single, born 27/5/1977, D.N.I. 26.001.156

 

 

History

 

As appears from the findings that have been made, the activities in question were initiated

and implemented by this society, which is governed by legal clauses above.

 

It is known that members of this society develop other commercial activities.

 

This is an Argentine laboratory from its genesis, is composed of human beings that share

principles that require them to assume a social responsibility.

 

They have a social function to be met by medical laboratories.

 

Your organization deal with the conviction of knowing that every day, get the best drugs in

the hands of health professionals.

 

 

 

Economic-Financial Position

 

Below we detail the figures of the Balance Sheet March 31, 2013 expressed in the currency of

our country.


CHANGE THE DATE OF THIS INFORMATION: 1 USD = $ 5.60 OFFICIAL

------------------------------------------------------------

TOTAL CURRENT ASSETS ......................10,862,837

TOTAL CURRENT ASSETS ...................... 2,774,009

TOTAL ASSETS ............................. 13,636,846

TOTAL CURRENT LIABILITIES ..................4,106,178

CTE TOTAL LIABILITIES ......................2,014,987

TOTAL EQUITY ...............................7,515,681

NET SALES .................................18,355,032

FINAL BALANCE ..............................3,517,308

 

 

ECONOMIC COMMENTARY

 

We are in a society that has an interesting investment, with good sales and having obtained

of the steps taken during the last exercise adequate final benefit which can reach

satisfactory considerse. –

 

Continue turning the company still favorable and smoothly

 

 

 

Assets

 

REAL ESTATE:

------------

- Avda. Gaona 3875, Buenos Aires City, Argentina.

Surface covered of 4000 m2.

VEHICLES:

---------

21 vehicles, are not obtained details.

 

 

Commercial References Consulted

 

DOBFAR SPA Italy

GRAFICA TGA S.A. Argentina

HETERO DRUGS LTD. India

LABORATORIOS FRASCA S.A. Argentina.

Payments: 90 days.

Crédits: u$s 50 and 75.000

Concept: Normal

 

 


Evolution and Results

 

Holder society is dedicated to the preparation and marketing of medical specialties for human use. -

 

Centralizes their actions in reporting the address where he has made reasonable operational structure.

 

In front of their own operations are responsible, with all partners 35 employees.

 

His action shows no unfavorable alternatives and who were consulted assigned stable outlook.

 

FOREIGN TRADE:

--------------

From India, Swizerland, Italy, Free zone of La Plata, Province of Buenos Aires, and Uruguay.

No export.

SOME OF YOUR PRODUCTS FOR ADULT AND PEDIATRIC:

----------------------------------------------

> AMOXI 500

> AMOXI DUO MAR

> CEFAMAR

> DICLOMAR

> METAMAR

> METAMAR RETARD, and others.

Work with the following companies:

----------------------------------

IOMA - IAPOS - IOSCOR - INSSSEP - OSEP - PAMI - OSPRERA

MAIN SUPPLIERS:

---------------

DOBFAR SPA Italy

HETERO DRUGS LTD. India

GRAFICA TGA S.A. Argentina

LABORATORIOS FRASCA S.A. Argentina

* 35 EMPLOYEES.

Official address of the company:

--------------------------------

Gaona Av 3875 | C1407FIA

City of Buenos Aires | Argentina

Tel. / Fax: (54 11) 4582-5090

dptocientifico@laboratoriosmar.com.ar

- rrhh@laboratoriosmar.com.ar

- administracion@laboratoriosmar.com.ar

 

 

Payment Record and Credit Risk

 

BANCO CREDICOOP

Suc. Villa Sahores

BANCO CIUDAD DE BUENOS AIRES

Suc. Villa del Parque


INSURANCE:

----------

NACION SEGUROS S.A.

CREDIT RISK JUNE 2013

---------------------

BANCO CIUDAD $ 848.400

BANCO CREDICOOP 233.100

SITUATION 1: NORMAL

 

 

Concept

 

No history against them.

 

Exercise has normal economic facilities makes use of credits according to the operational

needs of the moment.

 

The cancellation is maintained within certain time limits.

 

* ORDERED COMPLIANCE OBLIGATIONS.

 

 

Final Opinion

 

So once again we come to the conclusion that the treatment can credit with the informed party, operating in moderate amounts and with the guarantees of practice.

 

While noting its evolution and compliance.

 

* SUITABLE FOR NEW CREDITS.

CMA.


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.57

UK Pound

1

Rs.103.34

Euro

1

Rs.88.16

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.